首页> 美国卫生研究院文献>The FASEB Journal >Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition
【2h】

Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition

机译:淀粉样蛋白前体蛋白与Nogo受体之间的相互作用调节淀粉样蛋白的沉积

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Excessive production or accumulation of β-amyloid (Aβ) peptides in human brains leads to increased amyloid deposition and cognitive dysfunction, which are invariable pathological features in patients with Alzheimer's disease (AD). Many cellular factors can regulate the production of Aβ. In this study, we show that a family of proteins named Nogo receptor proteins (NgR1 to NgR3) regulates Aβ production via interaction with amyloid precursor protein (APP). Further mapping of the interacting domain indicates that a small region adjacent to the BACE1 cleavage site of APP mediates interaction of APP with Nogo receptor proteins. Our results also indicate that increased interaction between Nogo receptor and APP reduces surface expression of APP and favors processing of APP by BACE1. When NgR2 was ablated in AD transgenic mice expressing Swedish APP and PS1ΔE9, amyloid deposition was clearly reduced (0.66% of total measured area in APPswe/PS1ΔE9/NgR2−/− mice vs. 0.76% of total measured area in APPswe/PS1ΔE9 mice). Our results demonstrate that down-regulation of NgR expression is a potential approach for inhibiting amyloid deposition in AD patients.—Zhou, X., Hu, X., He, W., Tang, X., Shi, Q., Zhang, Z., Yan, R. Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition.
机译:β-淀粉样蛋白(Aβ)肽在人脑中的过量产生或积累导致淀粉样蛋白沉积和认知功能障碍的增加,这是阿尔茨海默病(AD)患者的不变病理特征。许多细胞因子可以调节Aβ的产生。在这项研究中,我们显示了一个名为Nogo受体蛋白(NgR1至NgR3)的蛋白家族通过与淀粉样蛋白前体蛋白(APP)的相互作用来调节Aβ的产生。相互作用域的进一步作图表明与APP的BACE1裂解位点相邻的小区域介导了APP与Nogo受体蛋白的相互作用。我们的结果还表明,Nogo受体与APP之间增强的相互作用会降低APP的表面表达,并有利于BACE1对APP的加工。当NgR2在表达瑞典APP和PS1ΔE9的AD转基因小鼠中被消融时,淀粉样蛋白沉积明显减少(APPswe /PS1ΔE9/ NgR2 -/-小鼠中总测量面积的0.66%,而总测量面积的0.76% (APPswe /PS1ΔE9小鼠的面积)。我们的研究结果表明,下调NgR表达是抑制AD患者淀粉样蛋白沉积的一种潜在方法。——周X.,胡X.,何W.,唐X.,施Q.,张Z.,Yan,R.淀粉样蛋白前体蛋白与Nogo受体之间的相互作用调节淀粉样蛋白的沉积。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号